These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5105870)

  • 41. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 42. Neurochemical correlates of behaviour. Changes in acetylcholine, norepinephrine and 5-hydroxytryptamine concentrations in several discrete brain areas of the rat during behavioural excitation.
    Aprison MH; Kariya T; Hingtgen JN; Toru M
    J Neurochem; 1968 Oct; 15(10):1131-9. PubMed ID: 5711126
    [No Abstract]   [Full Text] [Related]  

  • 43. The relative role of storage and synthesis of brain norepinephrine in the psychomotor stimulation evoked by amphetamine or by desipramine and tetrabenazine.
    Sulser F; Owens ML; Norvich MR; Dingell JV
    Psychopharmacologia; 1968; 12(4):322-32. PubMed ID: 5652215
    [No Abstract]   [Full Text] [Related]  

  • 44. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
    Fanelli O; Mazzoncini V; Trallori L
    Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
    [No Abstract]   [Full Text] [Related]  

  • 45. p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine.
    Strada SJ; Sanders-Bush E; Sulser F
    Biochem Pharmacol; 1970 Sep; 19(9):2621-9. PubMed ID: 5478286
    [No Abstract]   [Full Text] [Related]  

  • 46. Alteration of the neurochemical effects of fenfluramine by previous treatment with d-amphetamine.
    Hunsinger RN; Wilson MC
    Pharmacol Biochem Behav; 1985 Jan; 22(1):127-34. PubMed ID: 3975238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in catecholamine levels in discrete regions of rat brain during aging.
    Roubein IF; Embree LJ; Jackson DW
    Exp Aging Res; 1986; 12(4):193-6. PubMed ID: 3569394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in the concentration of biogenic monoamines in different brain regions under the influence of centrophenoxine (experiments on rats)].
    Petkov V; Konstantinova E; Zafirov D; Stancheva S
    Eksp Med Morfol; 1976; 15(4):233-6. PubMed ID: 189988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of repeated administration of DL-amphetamine and methamphetamine on tolerance to hyperactivity.
    Lu TC; Ho BT; McIsaac WM
    Experientia; 1972 Dec; 28(12):1461. PubMed ID: 4654213
    [No Abstract]   [Full Text] [Related]  

  • 50. An activity indicator of acute withdrawal depends on amphetamine dose in rats.
    White W; White IM
    Physiol Behav; 2006 Feb; 87(2):368-76. PubMed ID: 16364380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats.
    Paterson NE; Myers C; Markou A
    Psychopharmacology (Berl); 2000 Nov; 152(4):440-6. PubMed ID: 11140337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue.
    Frey HH; Magnussen MP
    Biochem Pharmacol; 1968 Jul; 17(7):1299-307. PubMed ID: 5659777
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 55. Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of alpha-methyltyrosine.
    Dominic JA; Moore KE
    Psychopharmacologia; 1969; 15(2):96-101. PubMed ID: 4390822
    [No Abstract]   [Full Text] [Related]  

  • 56. A slow-release silicone pellet for chronic amphetamine administration.
    Huberman HS; Eison MS; Bryan KS; Ellison G
    Eur J Pharmacol; 1977 Oct; 45(3):237-42. PubMed ID: 923636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphetamine sensitization in rats as an animal model of schizophrenia.
    Peleg-Raibstein D; Knuesel I; Feldon J
    Behav Brain Res; 2008 Aug; 191(2):190-201. PubMed ID: 18486243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of kinins on amphetamine activity.
    Moniuszko-Jakoniuk J; Kościelak M
    Pol J Pharmacol Pharm; 1976; 28(6):661-5. PubMed ID: 1012987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrastrain difference in serotonin and norepinephrine in discrete areas of rat brain.
    Miller FP; Cox RH; Maickel RP
    Science; 1968 Oct; 162(3852):463-4. PubMed ID: 5683055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.
    Chen JC; Su HJ; Huang LI; Hsieh MM
    Life Sci; 1999; 64(5):343-54. PubMed ID: 10072194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.